Form 8-K - Current report:
SEC Accession No. 0001213900-26-062844
Filing Date
2026-05-29
Accepted
2026-05-29 16:21:24
Documents
11
Period of Report
2026-05-27
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0292786-8k_aditxt.htm   iXBRL 8-K 32461
  Complete submission text file 0001213900-26-062844.txt   198375

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE adtx-20260527.xsd EX-101.SCH 3008
3 XBRL LABEL FILE adtx-20260527_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE adtx-20260527_pre.xml EX-101.PRE 22354
14 EXTRACTED XBRL INSTANCE DOCUMENT ea0292786-8k_aditxt_htm.xml XML 3208
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

EIN.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 261044792
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)